KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) EBITDA: 2016-2024

Historic EBITDA for Elanco Animal Health (ELAN) over the last 9 years, with Dec 2024 value amounting to -$1.5 billion.

  • Elanco Animal Health's EBITDA rose 149.25% to $167.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.0 million, marking a year-over-year increase of 105.29%. This contributed to the annual value of -$1.5 billion for FY2024, which is 51.54% up from last year.
  • Per Elanco Animal Health's latest filing, its EBITDA stood at -$1.5 billion for FY2024, which was up 51.54% from -$3.1 billion recorded in FY2023.
  • Over the past 5 years, Elanco Animal Health's EBITDA peaked at -$1.5 billion during FY2024, and registered a low of -$3.1 billion during FY2023.
  • In the last 3 years, Elanco Animal Health's EBITDA had a median value of -$2.0 billion in 2022 and averaged -$2.2 billion.
  • In the last 5 years, Elanco Animal Health's EBITDA plummeted by 68.39% in 2020 and then surged by 51.54% in 2024.
  • Yearly analysis of 5 years shows Elanco Animal Health's EBITDA stood at -$2.3 billion in 2020, then decreased by 15.32% to -$2.7 billion in 2021, then increased by 26.56% to -$2.0 billion in 2022, then crashed by 57.48% to -$3.1 billion in 2023, then surged by 51.54% to -$1.5 billion in 2024.